BriaCell Therapeutics Corp.
NASDAQ:BCTX
Overview | Financials
Company Name | BriaCell Therapeutics Corp. |
Symbol | BCTX |
Currency | USD |
Price | 0.39 |
Market Cap | 17,239,638 |
Dividend Yield | 0% |
52-week-range | 0.38 - 4.61 |
Industry | Biotechnology |
Sector | Healthcare |
CEO | Dr. William V. Williams M.D. |
Website | https://www.briacell.com |
An error occurred while fetching data.
About BriaCell Therapeutics Corp.
BriaCell Therapeutics Corp., an immuno-oncology biotechnology company, engages in developing immunotherapies for the treatment of cancer. Its lead candidate is Bria-IMT that is in Phase I/IIa clinical trial in a combination study with immune checkpoint inhibitors for the treatment of breast cancer. The company also has a cooperative research and
Related Stocks
Financials
Numbers are in millions USD
Numbers are in millions USD